Producing brightly speckled red and green snapshots of many different tissues, Johns Hopkins researchers have color-coded cells in female mice to display which of their two X chromosomes has been made inactive, or “silenced.” ...
Tags: X chromosomes, Johns Hopkins, color-coded cells, genetic diversity
One way to win the predictions game is to make a lot of guesses and remember just the winners. Here at IEEE Spectrum, we play a harder game. We told you what to expect in 2013, and now we are 'fessing up to our misses, as well as bragging ...
Tags: Postmortem, IEEE Spectrum
This is the CES of the wearable gadget. And, while there are all sorts of technologies you can wear-after all, earbuds are wearable-the big explosion is in fitness trackers. The first wave of these small gadgets, worn on a wrist, clipped on ...
Tags: CES 2014 Trends, CES 2014, Fitness Trackers, Smart Watches
A molecule nobody thought to explore may unlock a potential therapeutic target for a debilitating connective tissue disorder, according to Western-led research. Western professor Dr. David O'Gorman and PhD student Christina Raykha have ...
Tags: therapeutic target, connective tissue disorder, Dupuytren's disease
Harvard stem cells scientists at Brigham and Women's Hospital and MIT can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials ...
Tags: stem cells
Cilia—short, hair-like fibers—are widely present in nature. Single-celled paramecia use one set of cilia for locomotion and another set to sweep nutrients into their oral grooves. Researchers at Brown have discovered that those ...
Tags: Cilia, Single-celled paramecia, locomotion, fibers
A patient's own bone marrow stem cells might someday be used to treat multidrug-resistant tuberculosis, a new study suggests. The phase 1 study to assess the safety of the treatment included 30 patients, aged 21 to 65, with ...
The drugs Mekinist and Tafinlar were approved for combination treatment of advanced melanoma skin cancer, the U.S. Food and Drug Administration announced Friday. The two medicines "are the first drugs approved for combination treatment of ...
Tags: FDA, 2-Drug Combo Treatment, Combo Treatment for Advanced Melanoma
Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
A multi-disciplinary team from the University of Pennsylvania have published in Nature Methods a first-of-its-kind way to isolate RNA from live cells in their natural tissue microenvironment without damaging nearby cells. This allows the ...
Tags: Consumer Electronics, Electronics
EnergyTrend, a research division of TrendForce, indicates that since high-efficiency wafer supply shortage remains and demand is still strong, both buyers and sellers have started to plan for February orders ahead of time. It’s ...
Tags: Wafer, Raw Material
Some indigenous groups are more susceptible to the effects of the new strain of influenza -- H7N9 -- currently found in China, researchers in Australia said. Senior author Katherine Kedzierska, an associate professor of the University of ...
EnergyTrend indicates that cell manufacturers may revise the price upward to correspond to the increased poly and multi-si wafer price. Recent targeted average price is US$0.4/watt. “After poly price slightly declined in 2Q13, it ...
Tags: Cell, Poly, Multi-si Wafer
Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits ...
Biogen Idec (NASDAQ: BIIB) and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that ...